Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial

Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The new screenshot shows only minor UI adjustments (layout and header styling) with no changes to core study information such as eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-25T21:26:42.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Locations section refreshed: a single consolidated Locations section now lists Illinois, Maryland, Pennsylvania, and Quebec, replacing the previous separate location blocks. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.6%
    Check dated 2025-12-18T06:40:30.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Visual/UI changes are present (layout and styling adjustments) while core study details remain unchanged (eligibility criteria, outcomes, locations, etc.). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-11T01:38:18.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and updated the page revision to v3.3.2. The older PubMed wording was replaced.
    Difference
    0.2%
    Check dated 2025-11-25T14:29:05.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding and NIH operating status from the page; this is a non-core notification and does not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:24:10.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new screenshots; the page content and key details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-11T03:15:11.000Z thumbnail image

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.